Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder Bhaswati Guha Majumder Jul 14, 2021 06:42 PM +05:30 IST
US Decision To Not Give Emergency Authorisation To Bharat Biotech’s Covaxin Has Nothing To Do With Its EfficacySwarajya StaffJun 14, 2021 06:46 PM +05:30 IST
Why Pfizer And Moderna CEOs Are Recommending Covid-19 Vaccine Boosters, And Why Some Experts Don't Agree Yet Bhaswati Guha Majumder May 21, 2021 04:56 PM +05:30 IST
US FDA Recommends Pause On Johnson & Johnson's Single Dose Vaccine Following Blood Clot CasesSwarajya StaffApr 13, 2021 05:24 PM +05:30 IST
All You Need To Know About Johnson & Johnson’s Covid-19 Vaccine Trial In IndiaBhaswati Guha MajumderApr 10, 2021 05:16 PM +05:30 IST
Troubles Haven’t Ended For Johnson & Johnson: Baby Shampoo Fails Watchdog’s Quality Tests Swarajya StaffApr 2, 2019 12:09 PM +05:30 IST
When Stocks Get ‘Powdered’: Johnson & Johnson In Damage-Control Mode Amid Panic-Driven $40 Billion Share Sell-Off Swarajya StaffJan 1, 2019 05:59 PM +05:30 IST
Cancer-Causing Asbestos In Johnson & Johnson’s Baby Powder? India Set To Investigate Following Reuters ReportSwarajya StaffDec 19, 2018 06:11 PM +05:30 IST
Johnson & Johnson To Pay Compensation For Faulty Implants Following Government OrderSwarajya StaffSep 7, 2018 04:49 PM +05:30 IST